The Rise and Fall of E-Cigarettes Among Youth

Nov.30.2022
The Rise and Fall of E-Cigarettes Among Youth
The rise of e-cigarettes has led to a resurgence in teenage nicotine use, but regulatory action may be on the horizon.

At 21 years old, Ross is among a generation of nicotine users who became captivated by e-cigarettes when the technology and viral marketing strategies first emerged on social media. The advent of e-cigarettes has sparked a resurgence in nicotine use among American youth, reversing the decade-long downward trend in smoking rates. Today, 14.1% of high school students report using e-cigarettes. Despite the rapid rise in nicotine use, regulatory responses have been slow to materialize.


The FDA has received 8 million applications.


In 2020, the US Food and Drug Administration launched a requirement for all e-cigarette products to apply for and receive regulatory approval before they could continue to be sold on the market. The FDA allowed for some time lag in processing applications and stated that products could continue to be sold until their application was evaluated.


What happened next may help explain why the rate at which teenagers are using e-cigarettes has yet to slow down. Brian King, Director of the FDA Center for Tobacco Products, stated that the agency is overwhelmed with nearly 8 million applications for various e-cigarette products. He explained that each review must be conducted carefully because everything the FDA does, particularly the Center for Tobacco Products, is subject to litigation. "Therefore," he said, "on the front end, we ensure that everything we do is scientifically and legally sound, which is crucial and also takes time.


An FDA crackdown may be imminent.


According to Jin, the review process of the agency is nearing completion. Although he did not discuss the yet-to-be-released review results, experts anticipate that the FDA will intensify efforts to remove various e-cigarette products from the market in the upcoming months.


I think we will see products being removed from the market relatively quickly, these products have been the main cause of the teenage vaping epidemic," said Matthew Myers, President of the Campaign for Tobacco-Free Kids.


Miles and others point out that recent actions taken by the FDA are signs of an upcoming crackdown. This month, the FDA rejected an application for mint-flavored e-cigarettes from manufacturer Logic. This marks the first time the FDA has turned down a mint-based product, which it has long considered a separate category from other flavors. In June, the agency attempted to remove other e-cigarette products produced by Juul, a company that has gained widespread popularity due to the popularity of e-cigarettes. (This decision has not yet been implemented as Juul is appealing.)


Preventing children from using electronic cigarettes remains a top priority," said Jin.


Meanwhile, some states are taking their own measures, such as the recent ban on all flavored tobacco products including e-cigarettes and menthol in California. Massachusetts and Washington, D.C. have similar bans, while other states have limited bans on flavored products.


Other countries are also strengthening their regulations. China recently banned fruit-flavored e-cigarette products, and the EU is also considering a similar broad ban on flavors. Many other countries in Asia and the Middle East have completely banned e-cigarettes.


In the United States, experts including Matthew Myers, chairman of the Campaign for Tobacco-Free Kids, believe that the most effective form of prevention would be to target the equipment itself. Myers stated, "The most direct impact will come from shutting off the source.


While it may sound simple, Dr. Robert Jackler warns that regulatory agencies have been playing a game of cat and mouse with the tobacco industry. "By the time a regulatory agency implements a measure, the industry has already found 10 ways around it," said Jackler, a professor of medicine at Stanford University and a prominent researcher in tobacco marketing.


Recently, Jackler pointed out that the FDA's ban on flavored pods in 2020 did not have any impact on the rate of youth vaping. He stated that this is because the ban left a significant number of alternative technologies on the market, such as disposable devices and refillable pods. "It left an eight-lane escape highway," he said, as it is easy to obtain very similar substitutes with unregulated devices.


This is the recollection of Sam Rose, an electronic cigarette user from South Carolina, regarding the events of 2020. When the FDA cut off the supply of their favorite mango-flavored electronic pods, Rose and his teenage friends switched to a different flavor.


Almost everyone who tries it becomes addicted, so they just switch to mint flavor or disposable e-cigarette devices," Ross said.


This workaround drives parents like Meredith Berkman crazy. The co-founder of Parents Against Vaping E-Cigarettes claims that until this month, the FDA seemed unwilling to regulate or ban menthol, a reason she cannot comprehend.


Burkman stated, "This makes it easier for the poison to disappear, and until these flavored products are removed from the market, we really can't contain the teenage popularity of e-cigarettes, nor can we stop young children from starting to use e-cigarettes.


Jackler, a researcher from Stanford University, agrees and suggests that regulatory agencies need to take action against the three main factors that make e-cigarettes appealing to young people: "flavors, nicotine, and price.


For $20, a teenager can obtain nicotine equivalent to 800 cigarettes.


Jackler stated that the company has steadily increased the concentration of nicotine in its e-liquids, from around 1% to approximately 6% or higher. This makes e-cigarettes more addictive compared to tobacco products, and provides a very affordable source of nicotine. For $20, a teenager can purchase the nicotine equivalent of several packs of cigarettes - approximately 40 packs or 800 cigarettes.


To address this issue, Jackler believes that states and cities should impose taxes on electronic cigarettes at a rate similar to the high tax rate that most young people cannot afford for traditional cigarettes.


In less than four years, he spent over $10,000 on his electronic cigarette habit.


In fact, cost was a significant factor that motivated Sam Rose to quit smoking. He calculated that over a period of three and a half years, he spent over $10,000 on e-cigarettes by smoking a box and a half per day. "Every time I think about this number, I feel sick," he said.


However, his early attempts to quit smoking had failed until he opened up to his brother and mother. "She was surprised, but her attitude was, 'let's move forward!'" he said. "This completely changed the game." His sense of responsibility to his family helped him overcome the craving for nicotine until the smoking habit disappeared several weeks later.


Ross is currently a sophomore in college and serves as an ambassador for the Truth Initiative, an anti-smoking organization. He also manages a fast-food restaurant and works alongside his siblings and mother. He mentors a predominantly teenage staff, encouraging them to avoid e-cigarettes and taking them out for physical activities on weekends.


Ross said it was great to serve in this role, providing a safe space for people to feel secure and not worry about being bullied for not vaping or using similar products. He also noted that he has seen fewer people vaping in his community lately. Additionally, Ross said he feels closer to his mother than ever before and appreciates the sacrifices she has made for their family.


2FIRSTS will continue to cover this topic and provide updates on the "2FIRSTS APP". Scan the QR code below to download the app.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Australia Adds 6-Methylnicotine to Schedule 9 Prohibited Substances, Effective October 1
Australia Adds 6-Methylnicotine to Schedule 9 Prohibited Substances, Effective October 1
Australia's Therapeutic Goods Administration published a final decision on September 25 to classify 6-methylnicotine as a Schedule 9 prohibited substance under the Poisons Standard, effective October 1, 2026. TGA said the chemical has been reported in e-cigarette liquids sold in Australia and marketed as nicotine-free or nicotine alternatives, while evidence also indicates its use in preparations such as oral pouches. The government originally proposed a Schedule 7 classification but ultimately adopted the stricter Schedule 9 designation, citing acute toxicity, dependence risk, use in unapproved consumer products and misleading marketing.
News
Sep.29 by 2Firsts Perspectives
JTI Invests ₱2.1 Billion to Upgrade Batangas Manufacturing Hub, Adds First Southeast Asia DIET Facility
JTI Invests ₱2.1 Billion to Upgrade Batangas Manufacturing Hub, Adds First Southeast Asia DIET Facility
JTI Asia Manufacturing Corp. has invested ₱2.1 billion, or about $37 million, in its manufacturing site in Malvar, Batangas, Philippines, to expand tobacco-processing capabilities. About ₱1.9 billion is allocated to JTI's first Dry Ice Expanded Tobacco, or DIET, facility in Southeast Asia, while more than ₱177 million has been spent on expanding its Controlled Atmosphere treatment facility. The Batangas plant supplies the Philippine market and exports to 22 overseas markets, making it one of JTI's key manufacturing hubs in Asia.
Sep.24
Philip Morris Loses Two European Nicotine Pouch Patents in a Month Following BAT Challenges Over Nicotine Release and Formulation Technology
Philip Morris Loses Two European Nicotine Pouch Patents in a Month Following BAT Challenges Over Nicotine Release and Formulation Technology
The European Patent Office (EPO) published an appeal decision on November 17, 2026, revoking Philip Morris Products S.A.'s European nicotine pouch patent EP 3773494, covering a formulation involving free-base nicotine, ion-exchange resin and a water content of at least 15%. The decision followed an opposition and appeal brought by British American Tobacco (BAT) entity Nicoventures Trading Limited. Philip Morris withdrew its approval of the patent text during the appeal, leading the EPO to revoke the patent. A separate European patent, EP 3809884, covering the distribution of nicotine between a pouch membrane and its internal composition, had been revoked on September 24 following a challenge from another BAT entity. The patents share a 2019 priority basis, while related European divisional applications also exist.
company
Nov.18 by 2Firsts Perspectives
Product | JTI Introduces Fully Dissolvable PERLZ Nicotine Pearls in UK, Expands Range From 30-Pearl Dispensers to 10-Pearl Sachets
Product | JTI Introduces Fully Dissolvable PERLZ Nicotine Pearls in UK, Expands Range From 30-Pearl Dispensers to 10-Pearl Sachets
Japan Tobacco International (JTI) has introduced PERLZ nicotine pearls in the UK, expanding its oral nicotine portfolio beyond conventional nicotine pouches. The fully dissolvable, multi-layer pearls are placed under the tongue and come in Mint and Berry flavors at concentrations of 1mg/g and 2mg/g, equivalent to approximately 0.3mg and 0.5mg of nicotine per pearl. UK retailer Haypp published four 30-pearl dispenser listings on July 31, 2026, followed by three 10-pearl sachet products on August 17. The dispensers retail for £6.50, while the sachets cost £2.50.
product
Oct.12
US ITC Judge Finds Glas Infringed Two JUUL Vape Patents, Recommends Restrictions on Related Imports——Glas Received FDA Marketing Authorization for Four Vape Pods in May 2026; Proposed Restrictions Remain Under Commission Review
US ITC Judge Finds Glas Infringed Two JUUL Vape Patents, Recommends Restrictions on Related Imports——Glas Received FDA Marketing Authorization for Four Vape Pods in May 2026; Proposed Restrictions Remain Under Commission Review
A U.S. International Trade Commission (USITC) administrative law judge issued an initial determination on October 20, 2026, finding that certain Glas vaping devices, cartridges and components infringed 12 claims across two patents asserted by JUUL, constituting a violation of Section 337 of the Tariff Act of 1930. The judge recommended a limited exclusion order and a cease and desist order against the Glas respondents. Five months earlier, the FDA authorized four Glas e-cigarette pods, including mango, blueberry and two menthol variants. The patent investigation concerns device and cartridge structures and is separate from FDA premarket review. The proposed import restrictions have not become final, and their product-level scope remains unresolved.
company
Nov.05
Wall Street Journal: U.S. FDA Plans Faster Vape and Nicotine Pouch Reviews, Revisit of 2021 PMTA Rule
Wall Street Journal: U.S. FDA Plans Faster Vape and Nicotine Pouch Reviews, Revisit of 2021 PMTA Rule
The Trump administration is preparing changes intended to accelerate FDA market authorization reviews for e-cigarettes and nicotine pouches, according to The Wall Street Journal. The FDA is expected to revisit its 2021 PMTA rule and may simplify some scientific study requirements and shorten review times. The agency has not formally announced the changes. Over the past year, the FDA has already accelerated nicotine-pouch reviews, expanded ENDS authorizations and upgraded its CTP Portal NextGen application system. As of August 2026, 43 nicotine pouch products and 48 e-cigarette products had received FDA marketing authorization.
Sep.24